Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Kaori Yama"'
Autor:
Maiko Machida, Takuji Machida, Masaki Kikuchi, Ayaka Shimizu, Syunsuke Ida, Yoshiki Tawaraya, Risa Kato, Keisuke Haramaki, Kaori Yama, Saki Shiga, Masahiko Hirafuji, Kenji Iizuka
Publikováno v:
Journal of Pharmacological Sciences, Vol 148, Iss 3, Pp 281-285 (2022)
This study aimed to elucidate the role of nitric oxide (NO) in intestinal stem cells in methotrexate-induced ileal mucositis in rats. Methotrexate induced the mRNA expressions of the Wnt/β-catenin target genes Wnt3a, Sox9, and Lgr5 and the Wnt-antag
Externí odkaz:
https://doaj.org/article/de39600795a640d9ac9dd7c05b82e379
Publikováno v:
Women's Health Reports, Vol 3, Iss 1, Pp 267-273 (2022)
Background: The exact pathophysiology of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) is still unknown. This study aimed to investigate the concentration of 8-hydroxy-2?-deoxyguanosine (8-OHdG) in plasma in relation to the m
Externí odkaz:
https://doaj.org/article/3710c980daba4b9a94473f50490b93ed
Autor:
Kengo Umehara, Kaori Yama, Nozomi Koike, Shintarou Takayama, Azusa Wakamoto, Tae Hatuyama, Michiya Kobayashi, Hideki Sato
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-11 (2020)
Abstract Background Pemetrexed (PEM) is administered over a long term to patients with non-squamous cell lung cancer as a maintenance therapy after platinum combination induction chemotherapy. Although decreased renal function owing to long-term PEM
Externí odkaz:
https://doaj.org/article/9d62890c3b264ab6b1e4d2a2c68c8e4c
Publikováno v:
Women's Health Reports, Vol 1, Iss 1, Pp 73-79 (2020)
Background: The precise pathophysiology of premenstrual syndrome (PMS) is unknown, and chronic inflammation has been implicated in PMS. However, inflammatory markers, including cytokines and C-reactive protein (CRP), have not been investigated before
Externí odkaz:
https://doaj.org/article/92bb19a6d6cd46ebbe2a60f4b8ef25e1
Autor:
Kengo Umehara, Kaori Yama, Keisuke Goto, Azusa Wakamoto, Tae Hatsuyama, Osamu Honjo, Toyohiro Saikai, Akihisa Fujita, Hideki Sato
Publikováno v:
Cancer Control, Vol 28 (2021)
Introduction: Corticosteroids are used to treat immune-related adverse events (irAEs) associated with nivolumab. However, patients with non-small-cell lung cancer who are administered corticosteroids before the initiation of nivolumab treatment are c
Externí odkaz:
https://doaj.org/article/ecec087538944c1ea8719ec7d92f55e7
Publikováno v:
Redox Biology, Vol 4, Iss C, Pp 87-96 (2015)
Epalrestat (EPS) is the only aldose reductase inhibitor that is currently available for the treatment of diabetic neuropathy. Recently, we found that EPS at near-plasma concentration increases the intracellular levels of glutathione (GSH) in rat Schw
Externí odkaz:
https://doaj.org/article/513a35100e634ab2a18050f0a1eecc0d
Publikováno v:
Toxicology Reports, Vol 2, Iss C, Pp 1454-1462 (2015)
Schwann cell injury is caused by diabetic neuropathy. The apoptosis of Schwann cells plays a pivotal role in diabetic nerve dysfunction. Glycolaldehyde is a precursor of advanced glycation end products that contribute to the pathogenesis of diabetic
Externí odkaz:
https://doaj.org/article/2ceeffb5747c4c82a056262919cd387c
Publikováno v:
Redox Biology, Vol 2, Iss C, Pp 15-21 (2014)
Epalrestat (EPS), approved in Japan, is the only aldose reductase inhibitor that is currently available for the treatment of diabetic neuropathy. Here we report that EPS at near-plasma concentration increases the intracellular levels of glutathione (
Externí odkaz:
https://doaj.org/article/2c88452f71384225b26577dc3358177e
Serum Albumin Affects the Time-to-treatment Failure of Alectinib: A Multicenter Retrospective Study.
Autor:
KENGO UMEHARA, KAORI YAMA, KEISUKE GOTO, TAKANOBU HOSHI, TOMOAKI HATAKEYAMA, MARIKO ISAJI, SHINYA TAKADA, KAYO YAMAGISHI, KOZO MINO, HIDEKI SATO
Publikováno v:
In Vivo; Sep/Oct2023, Vol. 37 Issue 5, p2260-2267, 8p
Autor:
Kaori Yamashita, Keita Yoshida, Tetsushi Sakamoto, Satoshi Kubota, Takahiro Shiseki, Tadao Nakazawa, Yoji Nagashima, Masashi Inui
Publikováno v:
Renal Replacement Therapy, Vol 10, Iss 1, Pp 1-7 (2024)
Abstract Background End-stage renal disease is a risk factor for renal cell carcinoma. However, mucinous tubular and spindle cell carcinoma of the kidney is rare. We report a patient on hemodialysis who had high-grade mucinous tubular and spindle cel
Externí odkaz:
https://doaj.org/article/ceee5e2d3bdd463f9346477faac290bc